BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma-Reference-Cited by-同舟云学术

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Published:2017-07-19 Issue:20 Volume:23 Page:6203-6214
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Niessner Heike,Sinnberg Tobias,Kosnopfel Corinna,Smalley Keiran S.M.,Beck Daniela,Praetorius Christian,Mai Marion,Beissert Stefan,Kulms Dagmar,Schaller Martin,Garbe Claus,Flaherty Keith T.,Westphal Dana,Wanke Ines,Meier Friedegund

Funder

Federal Ministry of Education and Research

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of C/EBP Homologous Protein (CHOP) and Nupr1 Interaction in Endoplasmic Reticulum Stress-Induced Apoptosis of Lens Epithelial Cells;Molecular Biotechnology;2024-05-21

2. Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma;Journal for ImmunoTherapy of Cancer;2024-04

3. New clinical trial design in precision medicine: discovery, development and direction;Signal Transduction and Targeted Therapy;2024-03-04

4. Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF^V600/NRAS^Q61 Wild-Type Melanoma (TraMel-WT);JCO Precision Oncology;2024-02

5. Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy;Journal of Experimental & Clinical Cancer Research;2024-01-23